Water exercise versus land exercise for nerve damage from diabetes
Compares water-based exercise with land exercise in people with diabetic peripheral neuropathy.
Key facts
- Who runs it
- Beni-Suef University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Effect of Hydrotherapy On Pain, Balance and Quality of Life in Patients With Diabetic Peripheral Neuropathy
- Status
- Not yet recruiting
- People taking part
- 34 people, planned
- Started
- 1 Dec 2025
- Planned end
- 1 Mar 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Hydrotherapy training
- Land training
- Record updated
- 3 December 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with nerve damage in the feet or legs caused by type 2 diabetes. It compares water-based exercise (hydrotherapy) with exercise on land.
- Age
- 40 to 65 years
- Sex
- Men and women
- Disease stage
- Diabetic peripheral neuropathy from type 2 diabetes, confirmed by symptoms (such as numbness, tingling, burning pain) and a test such as nerve conduction studies. Type 2 diabetes for more than 10 years. No active infections or wounds.
- Biomarker or test result
- Stable blood sugar with HbA1c (≤5.7).
Main reasons for not taking part
- Severe kidney problems
- Uncontrolled heart or blood vessel disease
- Pregnancy
- Other nerve, muscle or bone conditions, or vitamin B12 deficiency
- Not able to safely get into or out of the pool, or low blood pressure on standing up
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- Diagnosis of diabetic peripheral neuropathy due to type 2 diabetes mellitus of both sex Patients must have confirmed diagnosis of diabetic peripheral neuropathy based on clinical symptoms (E.G, numbness, tingling and burning pain) and diagnostic test such as nerve conduction studies
- Chronicity of type 2 diabetes mellitus more than 10 years
- Age range: between 40-65years old
- Stable Blood Glucose Levels HbA1c (≤5.7)
- No active infections or wound
Who cannot take part
- Severe Renal Impairment
- Uncontrolled cardiovascular diseases
- Neurological or musculoskeletal conditions
- Uncontrolled infections
- Pregnancy
- Inability to safely enter or exit the pool
- Vitamin B12 deficiency
- Postural hypotension
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 40 and 65 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The current study aims to investigate the effects of hydrotherapy compared to land-based training on patients with diabetic peripheral neuropathy. It will evaluate hydrotherapy's impact on pain relief, sensation improvement, balance, and overall quality of life for these patients.
The 2 groups in the trial
- Hydrotherapy trainingTreatment being tested
This group will consist of seventeen diabetic peripheral neuropathy patients will perform hydrotherapy training for 12 weeks.
- Land trainingExisting treatment, for comparison
This group will consist of seventeen diabetic peripheral neuropathy patients will do land training for 12 weeks.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Hydrotherapy On Pain, Balance and Quality of Life in Patients With Diabetic Peripheral Neuropathy
- Plain-language title
- Water exercise versus land exercise for nerve damage from diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Fit questions
- Built from NCT07260214, who can take part
- Record updated
- 3 December 2025